Cargando…

Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease

BACKGROUND: Human β-defensin-2 (HBD2) is an antimicrobial peptide implicated in the pathogenesis of inflammatory bowel disease (IBD). Low copy number and concomitant low mRNA expression of the HBD2 gene have been implicated in susceptibility to colonic Crohn's Disease (CD). We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldhous, Marian C., Noble, Colin L., Satsangi, Jack
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708916/
https://www.ncbi.nlm.nih.gov/pubmed/19617917
http://dx.doi.org/10.1371/journal.pone.0006285
_version_ 1782169249483063296
author Aldhous, Marian C.
Noble, Colin L.
Satsangi, Jack
author_facet Aldhous, Marian C.
Noble, Colin L.
Satsangi, Jack
author_sort Aldhous, Marian C.
collection PubMed
description BACKGROUND: Human β-defensin-2 (HBD2) is an antimicrobial peptide implicated in the pathogenesis of inflammatory bowel disease (IBD). Low copy number and concomitant low mRNA expression of the HBD2 gene have been implicated in susceptibility to colonic Crohn's Disease (CD). We investigated the colonic distribution of HBD2 mRNA expression, and the contributions of genetic and environmental factors on HBD2 protein production. METHODOLOGY/PRINCIPAL FINDINGS: We examined HBD2 mRNA expression at three colonic locations by microarray analysis of biopsies from 151 patients (53 CD, 67 ulcerative colitis [UC], 31 controls). We investigated environmental and genetic influences on HBD2 protein production using ex vivo cultured sigmoid colon biopsies from 69 patients (22 CD, 26 UC, 21 controls) stimulated with lipopolysaccharide (LPS) and/or nicotine for 24 hours. HBD2 and cytokines were measured in culture supernatants. Using DNA samples from these patients, regions in the HBD2 gene promoter were sequenced for NF-κB binding-sites and HBD2 gene copy number was determined. HBD2 mRNA expression was highest in inflamed (vs. uninflamed p = 0.0122) ascending colon in CD and in inflamed (vs. uninflamed p<0.0001) sigmoid colon in UC. HBD2 protein production was increased in inflamed UC biopsies (p = 0.0078). There was no difference in HBD2 protein production from unstimulated biopsies of CD, UC and controls. LPS-induced HBD2 production was significantly increased in CD (p = 0.0375) but not UC (p = 0.2017); this LPS-induced response was augmented by nicotine in UC (p = 0.0308) but not CD (p = 0.6872). Nicotine alone did not affect HBD2 production. HBD2 production correlated with IL8 production in UC (p<0.001) and with IL10 in CD (p<0.05). Variations in the HBD2 promoter and HBD2 gene copy number did not affect HBD2 production. SIGNIFICANCE/CONCLUSIONS: Colonic HBD2 was dysregulated at mRNA and protein level in IBD. Inflammatory status and stimulus but not germline variations influenced these changes.
format Text
id pubmed-2708916
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-27089162009-07-20 Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease Aldhous, Marian C. Noble, Colin L. Satsangi, Jack PLoS One Research Article BACKGROUND: Human β-defensin-2 (HBD2) is an antimicrobial peptide implicated in the pathogenesis of inflammatory bowel disease (IBD). Low copy number and concomitant low mRNA expression of the HBD2 gene have been implicated in susceptibility to colonic Crohn's Disease (CD). We investigated the colonic distribution of HBD2 mRNA expression, and the contributions of genetic and environmental factors on HBD2 protein production. METHODOLOGY/PRINCIPAL FINDINGS: We examined HBD2 mRNA expression at three colonic locations by microarray analysis of biopsies from 151 patients (53 CD, 67 ulcerative colitis [UC], 31 controls). We investigated environmental and genetic influences on HBD2 protein production using ex vivo cultured sigmoid colon biopsies from 69 patients (22 CD, 26 UC, 21 controls) stimulated with lipopolysaccharide (LPS) and/or nicotine for 24 hours. HBD2 and cytokines were measured in culture supernatants. Using DNA samples from these patients, regions in the HBD2 gene promoter were sequenced for NF-κB binding-sites and HBD2 gene copy number was determined. HBD2 mRNA expression was highest in inflamed (vs. uninflamed p = 0.0122) ascending colon in CD and in inflamed (vs. uninflamed p<0.0001) sigmoid colon in UC. HBD2 protein production was increased in inflamed UC biopsies (p = 0.0078). There was no difference in HBD2 protein production from unstimulated biopsies of CD, UC and controls. LPS-induced HBD2 production was significantly increased in CD (p = 0.0375) but not UC (p = 0.2017); this LPS-induced response was augmented by nicotine in UC (p = 0.0308) but not CD (p = 0.6872). Nicotine alone did not affect HBD2 production. HBD2 production correlated with IL8 production in UC (p<0.001) and with IL10 in CD (p<0.05). Variations in the HBD2 promoter and HBD2 gene copy number did not affect HBD2 production. SIGNIFICANCE/CONCLUSIONS: Colonic HBD2 was dysregulated at mRNA and protein level in IBD. Inflammatory status and stimulus but not germline variations influenced these changes. Public Library of Science 2009-07-20 /pmc/articles/PMC2708916/ /pubmed/19617917 http://dx.doi.org/10.1371/journal.pone.0006285 Text en Aldhous et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Aldhous, Marian C.
Noble, Colin L.
Satsangi, Jack
Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
title Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
title_full Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
title_fullStr Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
title_full_unstemmed Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
title_short Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease
title_sort dysregulation of human β-defensin-2 protein in inflammatory bowel disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708916/
https://www.ncbi.nlm.nih.gov/pubmed/19617917
http://dx.doi.org/10.1371/journal.pone.0006285
work_keys_str_mv AT aldhousmarianc dysregulationofhumanbdefensin2proteinininflammatoryboweldisease
AT noblecolinl dysregulationofhumanbdefensin2proteinininflammatoryboweldisease
AT satsangijack dysregulationofhumanbdefensin2proteinininflammatoryboweldisease